LaSalle Street Capital Management’s Evolent Health EVH Stock Holding History

LaSalle Street Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-35,366	Closed	-$445K	–	88
2019 Q1	$445K	Buy	35,366 +12,788	+57%	+$202K	0.52%	55
2018 Q4	$450K	Hold	22,578	–	–	0.65%	55
2018 Q3	$641K	Buy	22,578 +9,422	+72%	+$225K	0.75%	51
2018 Q2	$277K	Buy	+13,156	New	+$249K	0.28%	92

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

LaSalle Street Capital Management's EVH Position: Q2 2019 in Review

LaSalle Street Capital Management sold out of Evolent Health (EVH) in Q2 2019, closing a stake of 35,366 shares — an estimated $445K sold.

LaSalle Street Capital Management first reported a position in EVH in Q2 2018 and held it in 4 quarters. The position peaked at $641K in Q3 2018. 183 funds tracked by Wall St. Rank hold EVH as of Q2 2019.

LaSalle Street Capital Management reported no remaining Evolent Health position as of Q2 2019 after selling out during the quarter.
LaSalle Street Capital Management sold 35,366 Evolent Health shares in Q2 2019, an estimated $445K.
LaSalle Street Capital Management first reported a position in Evolent Health in Q2 2018 and held it in 4 quarters.
LaSalle Street Capital Management's Evolent Health position peaked at $641K in Q3 2018.
183 funds tracked by Wall St. Rank held Evolent Health as of Q2 2019.

Based on LaSalle Street Capital Management's 13F filing for Q2 2019, filed 8 Aug 2019.